Found: 12
Select item for more details and to access through your institution.
A novel inactivated virus system (InViS) for a fast and inexpensive assessment of viral disintegration.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-15471-5
- By:
- Publication type:
- Article
A SARS-CoV-2 Wuhan spike virosome vaccine induces superior neutralization breadth compared to one using the Beta spike.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-07590-w
- By:
- Publication type:
- Article
Insect Cells for High-Yield Production of SARS-CoV-2 Spike Protein: Building a Virosome-Based COVID-19 Vaccine Candidate.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 4, p. N.PAG, doi. 10.3390/pharmaceutics14040854
- By:
- Publication type:
- Article
A low dose of RBD and TLR7/8 agonist displayed on influenza virosome particles protects rhesus macaque against SARS-CoV-2 challenge.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-31818-y
- By:
- Publication type:
- Article
Peripherally Administered Nanoparticles Target Monocytic Myeloid Cells, Secondary Lymphoid Organs and Tumors in Mice.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0061646
- By:
- Publication type:
- Article
Immunogenicity and Protective Capacity of a Virosomal Respiratory Syncytial Virus Vaccine Adjuvanted with Monophosphoryl Lipid A in Mice.
- Published in:
- PLoS ONE, 2012, v. 7, n. 5, p. 1, doi. 10.1371/journal.pone.0036812
- By:
- Publication type:
- Article
Enhanced HPV16 E6/E7<sup>+</sup> tumor eradication via induction of tumor-specific T cells by therapeutic vaccination with virosomes presenting synthetic long peptides.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2851, doi. 10.1007/s00262-023-03462-y
- By:
- Publication type:
- Article
Membrane Fusion Mechanisms: The Influenza Hemagglutinin Paradigm and its Implications for Intracellular Fusion.
- Published in:
- Traffic, 2000, v. 1, n. 8, p. 598, doi. 10.1034/j.1600-0854.2000.010803.x
- By:
- Publication type:
- Article
New GMP manufacturing processes to obtain thermostable HIV-1 gp41 virosomes under solid forms for various mucosal vaccination routes.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-0190-9
- By:
- Publication type:
- Article
Bet v 1 contiguous overlapping peptides anchored to virosomes with TLR4 agonist enhance immunotherapy efficacy in mice.
- Published in:
- Clinical & Experimental Allergy, 2021, v. 51, n. 2, p. 339, doi. 10.1111/cea.13814
- By:
- Publication type:
- Article
A virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A provides protection against viral challenge without priming for enhanced disease in cotton rats.
- Published in:
- Influenza & Other Respiratory Viruses, 2013, v. 7, n. 6, p. 1227, doi. 10.1111/irv.12112
- By:
- Publication type:
- Article
Spontaneous lipid vesicle fusion with electropermeabilized cells
- Published in:
- FEBS Letters, 2002, v. 518, n. 1-3, p. 135, doi. 10.1016/S0014-5793(02)02676-5
- By:
- Publication type:
- Article